- Technical notes
- Cellartis MSC Xeno-Free Culture Medium
- Cellartis Power Primary HEP Medium
- Cellartis DEF-CS 500 Culture System
- Cellartis Enhanced hiPS-HEP cells
- Cellartis hES-MP 002.5
- Cellartis hPS cell-derived cardiomyocytes
- Cellartis iPS Cell to Hepatocyte Differentiation System
- 2i mES/iPSC medium
- 3i mES/iPSC medium
- NDiff 227
- NDiff N2
- Selection guides
Cellartis MSC Xeno-Free Culture Medium citation list
Cellartis MSC Xeno-Free Culture Medium provides optimal conditions that enable the maintenance and expansion of human mesenchymal stem cells (MSCs) from bone marrow, adipose tissue, or umbilical cord without plate coating reagents. Importantly, MSCs maintain multilinear differentiation ability and display a stable phenotype during the culture period.
Read below for a citation list of studies in which the Cellartis MSC Xeno-Free Culture Medium was used in peer-reviewed research.
Li, F. et al. Mesenchymal stem cell‑derived extracellular vesicles prevent neural stem cell hypoxia injury via promoting miR‑210‑3p expression. Mol. Med. Rep. 22, 3813–3821 (2020).
The study investigated the effects of MSC‑derived extracellular vesicles (EVs) on neural stem cell (NSC) injury, as well as the underlying mechanisms. MSCs were cultured in Cellartis MSC Xeno-Free Culture Medium. MSC-derived extracellular vesicles were isolated from the medium and used to treat a model of NSC hypoxic injury. The authors found that MSC-EVs can prevent injury by promoting miR-210-3p expression.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2020 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.